 |
Doug Macron is the editor of GenomeWeb's Gene Silencing News. He covers research and therapeutic applications of RNAi, miRNA, and other gene-silencing technologies. E-mail Doug Macron or follow his GenomeWeb Twitter account at @Genesilencing. |
Dicerna Selects Target, Delivery Tech for First Clinical Candidate
May 24, 2012
Dicerna Selects Target, Delivery Tech for First Clinical Candidate
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Kyowa Selects Second Cancer Drug Candidate under Dicerna Partnership
January 3, 2013 / Gene Silencing News - Dicerna Aims for Partnership in '12, IND in '13
December 22, 2011 / Gene Silencing News - Dicerna Earns $5M Milestone as Partner Kyowa Picks up Cancer Drug
December 15, 2011 / Gene Silencing News - Dicerna Finds RNAi-Savvy Partner in Kyowa for Cancer Drug Program
January 7, 2010 / Gene Silencing News - Tekmira Releases Phase I Cancer Drug Data, Plans Phase II Trial in Neuroendocrine Tumors
April 11, 2013 / Gene Silencing News